Skip to main content

TTK Healthcare Limited (TTKHLTCARE.NS)

National Stock Exchange of India Healthcare Drug Manufacturers - GeneralView data quality →
63.6Fair

ValueMarkers Composite Index

Top 90%#4,429 of 44,707
Undervalued

88% below intrinsic value ($87)

UndervaluedFair ValueOvervalued
Piotroski
5/9
Neutral
Beneish
0.61
High Risk
Altman
6.93
Safe
DCF Value
$87
Undervalued
ROIC
24.8%
Strong
P/E
20.4
Fair
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

TTK Healthcare Limited (TTKHLTCARE.NS) — VMCI valuation read

Composite valuation read on TTKHLTCARE.NS: VMCI 64/100 against a Healthcare sector median of 50. The 14-point above-median print is the headline number for TTK Healthcare Limited, and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.

Trailing 30-day insider activity for TTKHLTCARE.NS: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.

**Investor frame.** Value, quality, risk in three lines on TTKHLTCARE.NS: TTKHLTCARE.NS trades at 21.0x earnings, 17% above the Healthcare median of 18.0x; ROIC of 17.0% sits 7.0pp above the Healthcare median (10.0%); net debt to EBITDA of 0.4x leaves covenant headroom. EV/EBITDA at 14.0x versus 12.0x for Healthcare closes the value frame.

TTKHLTCARE.NS rose 1.0% over the trailing 7 days, with a -15.4% read on a 30-day basis.

TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, and food businesses in India and internationally. Its Animal Welfare segment deals in various therapeutic formulations and feed supplements for veterinary use. The company's Consumer Products segment is involved in the marketing and distribution of Woodward's Gripewater, EVA range of cosmetics, Good Home range of scrubbers, air fresheners, etc. its Medical Devices segment manufactures and distributes artificial heart valves; and develops orthopedic implants and instruments. The company's Protective Devices segment manufactures and markets male contraceptives and other allied products. Its Foods segment engages in the manufacturing and marketing of food products, including potato and cereal based pellets. The company's Others segment prints and publishes maps and atlases. Its Human Pharma segment deals in herbal and allopathic formulations for human use. The company was incorporated in 1958 and is headquartered in Chennai, India. TTK Healthcare Limited is a subsidiary of TT Krishnamachari & Co., Ltd.

CEO: S. Kalyanaraman1,316 employeesINwww.ttkhealthcare.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in TTKHLTCARE.NS’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.